Canadian Firm to Operate Alongside Existing Process Sensing Technologies Companies Michell Instruments, Analytical Industries and Rotronic BOSTON, SAN FRANCSICO AND HERZLIYA, Israel–(June 6, 2018) – Battery Ventures, a global technology investment firm, has reached an agreement for its platform in the process-measurement market, Process Sensing Technologies (PST), to acquire LDetek, a global manufacturer of gas chromatography instruments and online analyzers. LDetek, which is based in Thetford Mines, Quebec, will join Battery’s existing portfolio of process-measurement and instrumentation companies. These include Analytical Industries Inc. and Michell Instruments, both acquired in 2016, and Rotronic AG, acquired in 2017. Terms of the LDetek transaction were not disclosed. Founded in 2009, LDetek now has a significant global footprint and is a well-known provider of gas chromatography and online analyzer products. The company uses a proprietary plasma-emission detector (“PED”) technology to deliver highly sensitive measurement capabilities to customers in industries such as such as specialty / high purity gas, semiconductors, laboratories, and environmental monitoring. The company was founded by Louis Paradis and Dany Gagne, both of whom will continue on as president and CTO, respectively. They will work closely with PST Group CEO Adam Markin to manage the business. “LDetek’s focus on gas chromatography and analysis is extremely complementary to the other businesses in PST’s portfolio, and will enable PST to offer a complete solution in a number of key applications,” said Markin. “We are excited to welcome LDetek to the global PST family.” “We’re very much looking forward to joining the PST group of companies and believe this partnership will provide LDetek with many valuable resources as we continue to grow and develop our business globally,” said Louis Paradis, LDetek’s president. Added Dany Gagne, CTO: “We see many synergies in this partnership and are excited to work with PST and Battery.” About Battery Battery strives to invest in category-defining businesses in markets including software and services, Web infrastructure and industrial technologies. Founded in 1983, the firm backs companies at stages ranging from seed to private equity and invests globally from offices in Boston, the San Francisco Bay Area, Israel, London and New York. Follow the firm on Twitter @BatteryVentures, visit our website at www.battery.com and find a full list of Battery’s portfolio companies here. About LDetek LDetek designs and manufactures gas chromatography solutions, including highly sensitive detectors; high-performance, patented, stand-alone gas chromatographic systems; compact online analyzers; and accessories for applications in industrial gas, semiconductor, environmental, energy, and food and beverage end markets. LDetek was founded in 2009 and operates from its headquarters in Thetford Mines, Quebec, Canada.

/in , /by

(San Diego, Calif.) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, today announces the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions. Heilmann will lead the newly formed division to achieve its mission of […]

Read more →

CARON APPOINTS ART HEY AS REGIONAL SALES MANAGER

/in , /by

(Marietta, OH)  Art Hey has been appointed Mid-Atlantic Regional Sales Manager for Caron Products & Services, Inc.  Art will be responsible for managing all Caron sales activity in a newly-created territory which includes DC, KY, MD, NC, VA, and WV.  With the territory realignment and creation of the Mid-Atlantic region, Caron now supports its U.S. […]

Read more →

BD Names John DeFord Chief Technology Officer

/in /by

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed John A. DeFord as executive vice president and chief technology officer. DeFord, 56, will report to Tom Polen, president of BD, and will be responsible for leading all research and development (R&D) activities for the company, including developing the current and […]

Read more →

Riffyn Forms Advisory Board of Biopharm and Biotech R&D Innovators

/in , /by

OAKLAND, Calif. – Riffyn, a provider of cloud-based R&D software, announces that Per Falholt and Devendra Deshmukh have joined Riffyn’s Advisory Board. Mr. Falholt previously served as the head of Novozymes R&D. Mr. Deshmukh most recently served as the Executive Director of R&D IT at Merck Sharp & Dohme. “We are thrilled to have Per and […]

Read more →

Additions to Artel Sales, Marketing and Finance Teams to Drive Company-wide Growth

/in , /by

Focusing on the continued growth of its business and the expansion of its overall liquid measurement and handling capabilities, Artel recently brought three new team members aboard, each aimed at helping propel a specific area of the company’s growth strategy. “Our goal has always been to become the go-to provider of liquid handling solutions for lab scientists, […]

Read more →

908 Devices Bolsters Life Science Leadership, Welcomes Nicolas Barthelemy to Board of Directors

/in , /by

908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced the recent appointment of Nicolas Barthelemy to its Board of Directors. Nicolas brings over 25 years of extensive life science expertise to the company, and a long-standing track record in the manufacturing, distribution and commercialization of scientific instrumentation, reagents and services. Nicolas […]

Read more →

Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO

/in , , , /by

Results-driven, customer-focused leader to drive continued expansion in personalized medicine, disease research markets (ANN ARBOR, Mich.) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today named industry veteran Nathan Wood as its new CEO. The hire is the latest in a recent series of strategic moves by Swift to solidify its […]

Read more →

Horizon Discovery Group plc Board Change

/in , /by

Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Group” or “the Company”), a global leader in gene editing and gene modulation technologies, announces that Dr. Jonathan Milner is stepping down from his position as a Non-Executive Director of the Board with immediate effect. Commenting on this announcement, Dr. Jonathan Milner said: “After 10 very enjoyable years […]

Read more →

Scientifica’s new Research and Development Manager – Christian Wilms

/in , /by

Scientifica are excited to announce that Christian Wilms is taking on the role of Research and Development Manager. Coming from a neuroscience research background, with more than a decade of experience in electrophysiology and fluorescence imaging, Christian joined Scientifica’s R&D team as Applications Specialist early in 2016. His role involved extending the capabilities of Scientifica’s […]

Read more →

Lab7 Systems Appoints New CEO and Changes Name to L7 Informatics

/in , , /by

AUSTIN, Texas — Lab7 Systems, a leader in informatics solutions and services for data intensive scientific applications and personalized medicine, announced today its name change L7 Informatics, Inc. to reflect the expansion of its product offering. In conjunction with the name change, L7 is proud to announce the appointment of Vasudev Rangadass, Ph.D., as its […]

Read more →